FDA NDC Directory · JSON-LD · Markdown

Irbesartan and Hydrochlorothiazide

NDC 62332-052 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091370
Dosage form / routeTABLET · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (12.5 mg/1)
IRBESARTAN (300 mg/1)
Marketing started20160523
Package count4

External sources

Source: openFDA. Public-domain (CC0).